Aureus Asset Management, LLC Johnson & Johnson Transaction History

Aureus Asset Management, LLC

$1.43 Billion
Q2 2024

A detailed history of Aureus Asset Management, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Aureus Asset Management, LLC holds 27,191 shares of JNJ stock, worth $4.52 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

27,191

Previous 29,682 8.39%

Holding current value

$4.52 Million

Previous $4.7 Million 15.36%

% of portfolio

0.28%

Previous 0.32%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$144.38 - $157.78 $359,650 - $393,029	-2,491 Reduced 8.39%	27,191 $3.97 Million
Q1 2024 May 13, 2024	SELL	$155.22 - $162.74 $277,999 - $291,467	-1,791 Reduced 5.69%	29,682 $4.7 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $895,585 - $977,270	-6,151 Reduced 16.35%	31,473 $4.93 Million
Q3 2023 Nov 13, 2023	BUY	$155.75 - $174.48 $133,166 - $149,180	855 Added 2.33%	37,624 $5.86 Million
Q2 2023 Aug 11, 2023	SELL	$154.35 - $166.11 $1.39 Million - $1.5 Million	-9,017 Reduced 19.69%	36,769 $6.09 Million
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $81,567 - $97,340	540 Added 1.19%	45,786 $7.1 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $35,564 - $39,913	222 Added 0.49%	45,246 $7.99 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $330,081 - $367,297	-2,046 Reduced 4.35%	45,024 $7.36 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $1.14 Million - $1.26 Million	6,787 Added 16.85%	47,070 $8.36 Million
Q1 2022 May 12, 2022	SELL	$158.14 - $179.59 $605,834 - $688,009	-3,831 Reduced 8.68%	40,283 $7.14 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $888,333 - $985,637	-5,697 Reduced 11.44%	44,114 $7.55 Million
Q3 2021 Nov 12, 2021	BUY	$161.5 - $179.47 $119,348 - $132,628	739 Added 1.51%	49,811 $8.04 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $3.27 Million - $3.51 Million	20,489 Added 71.68%	49,072 $8.08 Million
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $534,367 - $595,145	3,491 Added 13.91%	28,583 $4.7 Million
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $242,547 - $278,405	-1,769 Reduced 6.59%	25,092 $3.95 Million
Q3 2020 Nov 13, 2020	SELL	$140.38 - $153.83 $9,265 - $10,152	-66 Reduced 0.25%	26,861 $4 Million
Q2 2020 Aug 11, 2020	BUY	$128.81 - $155.51 $115,542 - $139,492	897 Added 3.45%	26,927 $3.79 Million
Q1 2020 May 14, 2020	BUY	$111.14 - $153.99 $559,701 - $775,493	5,036 Added 23.99%	26,030 $3.41 Million
Q4 2019 Feb 12, 2020	SELL	$127.5 - $146.44 $212,287 - $243,822	-1,665 Reduced 7.35%	20,994 $3.06 Million
Q3 2019 Nov 12, 2019	SELL	$126.95 - $142.14 $67,537 - $75,618	-532 Reduced 2.29%	22,659 $2.93 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $464,139 - $510,465	-3,539 Reduced 13.24%	23,191 $3.23 Million
Q1 2019 May 13, 2019	SELL	$125.72 - $139.79 $63,362 - $70,454	-504 Reduced 1.85%	26,730 $3.74 Million
Q4 2018 Feb 13, 2019	SELL	$122.84 - $147.84 $171,116 - $205,941	-1,393 Reduced 4.87%	27,234 $3.51 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $101,640 - $119,447	-836 Reduced 2.84%	28,627 $3.96 Million
Q2 2018 Aug 13, 2018	SELL	$119.4 - $131.76 $131,578 - $145,199	-1,102 Reduced 3.61%	29,463 $3.58 Million
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $37,905 - $44,886	-303 Reduced 0.98%	30,565 $3.92 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $70,333 - $76,980	536 Added 1.77%	30,868 $4.31 Million
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $3.93 Million - $4.11 Million	30,332	30,332 $3.94 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aureus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aureus Asset Management, LLC with notifications on news.

Account

Aureus Asset Management, LLC Johnson & Johnson Transaction History